🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited related keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.

Within minutes of joining one group, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Product Details and Costs

Within these groups, messages display dark colored parcels with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.